Table 1. [Part 1]. Description of Studies in Eastern Mediterranean Region Office (EMRO) and Middle Eastern Countries That Met Our Eligibility Criteria.

Country	Pub. year	Male, %	Sample Size	HBsAg Prevalence (95% CI)
Cyprus (M)
Altindis, M.	2006	NR	5,057	3 (2.54 – 3.45)
Djibouti (E)
Dray, X.	2005	NR	9,006	10.4 (10.2 – 10.59)
Egypt (E and M)
Eissa, S. A.	2007	NR	99,757	1.3 (1.23 – 1.35)
El-Gilany, A. H.	2006	62.6	2,157	4.31 (3.46 – 5.15)
Habil, F. E.	2013	NR	12,000	1.98 (1.74 – 2.21)
Hussein, E.	2014	NR	308,762	1.22 (1.18 – 1.25)
Ismail, A. M.	2009	93	55,922	1.3 (1.22 – 1.37)
Khattab, M. A.	2009	85	211,772	1.65 (1.59 – 1.7)
Wasfi, O. A. S.	2011	NR	3,420	1.4 (1.00 – 1.79)
Iran (E and M)
Afzali, H.	2002	90	43,731	0.62 (0.54 – 0.69)
Aghamohamad, A.	2014	NR	124,704	0.24 (0.21 – 0.26)
Kafi-Abad, S. A.	2009	91	14,599,783	0.96 (0.95 – 0.96)
Bozorgi, S. H.	2012	92	20,591	0.23 (0.17 – 0.28)
Mansour Ghanaei, F.	2008	97.8	221,508	0.45 (0.42 – 0.47)
Ghavanini, A. A.	2000	NR	7,879	1.07 (0.85 – 1.28)
Emamghorashi	2006	93	3,000	0.4 (0.18 – 0.61)
Jabbari, H.	2008	95.7	5,409	2.4 (2.00 – 2.79)
Karimi, A.	2008	NR	35,124	0.1 (0.07 – 0.14)
Kasraian, L.	2012	NR	96,646	0.27 (0.213 – 0.3)
Khedmat, H.	2007	NR	318,029	0.52 (0.49 – 0.54)
Khedmat, H.	2009	NR	1,004,889	0.6 (0.58 – 0.61)
Maneshi, H. O.	2010	NR	51,884	0.47 (0.41 – 0.52)
Masaeli, Z.	2006	90	29,458	0.5 (0.42 – 0.58)
Mohammadali, F.	2014	NR	2,026,628	0.38 (0.38 – 0.39)
Samadi, M.	2014	96	2,108	0.19 (0.17 – 0.21)
Vahid, T.	2005	NR	39,598	1.08 (0.98 – 1.18)
Sorouri Zanjani, R.	2013	89	29,716	0.35 (0.28 – 0.41)

Abbreviations: E, EMRO countries; E and M, all countries from the two regions; M, middle eastern countries; NR, not reported.